RGEN Q4 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$187M+71.7% YoY

Gross Profit

$104M56.0% margin

Operating Income

$37M20.1% margin

Net Income

$29M15.6% margin

EPS (Diluted)

$0.50

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

$16M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$608M

Stockholders' Equity

$1.8B

Cash & Equivalents

$604M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$187M	$109M	+71.7%
Gross Profit	$104M	$56M	+86.0%
Operating Income	$37M	$22M	+67.5%
Net Income	$29M	$20M	+47.8%

Revenue Segments

Product

$186M100%

Royalty

$36,0000%